Risk factors for progression to incident hyperinsulinemia: The Atherosclerosis Risk in Communities Study, 1987-1998

被引:99
作者
Carnethon, MR
Fortmann, SP
Palaniappan, L
Duncan, BB
Schmidt, MI
Chambless, LE
机构
[1] Stanford Univ, Sch Med, Stanford Ctr Res Dis Prevent, Palo Alto, CA 94304 USA
[2] Univ Fed Rio Grande do Sul, Sch Med, Dept Social Med, Porto Alegre, RS, Brazil
[3] Univ N Carolina, Sch Publ Hlth, Dept Biostat, Chapel Hill, NC USA
关键词
diabetes; non-insulin-dependent; hyperinsulinemia; insulin resistance; longitudinal studies; metabolic syndrome X; risk factors;
D O I
10.1093/aje/kwg260
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Hyperinsulinemia is a marker of insulin resistance, a correlate of the metabolic syndrome, and an established precursor of type 2 diabetes. This US study investigated the role of risk factors associated with hyperinsulinemia in cross-sectional studies in progression to incident hyperinsulinemia. Nondiabetic participants from the Atherosclerosis Risk in Communities Study (n = 9,020) were followed from 1987 to 1998 for the development of hyperinsulinemia (fasting serum insulin greater than or equal to90th percentile, 19.1 muU/ml). After adjustment for demographic characteristics, all risk factors simultaneously, and baseline insulin value, the risk of progressing to hyperinsulinemia increased per standard deviation increase in baseline uric acid (odds ratio (OR) = 1.3, 95% confidence interval (Cl): 1.2,1.4; per 1.4 mg/dl) and waist/hip ratio (OR = 1.4, 95% Cl: 1.2,1.5; per 0.08) and was inversely associated with high density lipoprotein cholesterol (OR = 0.8, 95% Cl: 0.7, 0.9; per 0.4 mmol/liter). Starting to smoke (OR = 1.5, 95% Cl: 1.2, 2.0) and becoming obese (OR = 2.4, 95% Cl: 1.8, 3.1) during the study were also associated with increased risk. The associations were similar across race and gender groups. These data suggest that, in addition to weight gain, hyperuricemia, dyslipidemia, and smoking can be detected prior to development of hyperinsulinemia.
引用
收藏
页码:1058 / 1067
页数:10
相关论文
共 54 条
[1]   SMOKING INDUCES INSULIN RESISTANCE - A POTENTIAL LINK WITH THE INSULIN RESISTANCE SYNDROME [J].
ATTVALL, S ;
FOWELIN, J ;
LAGER, I ;
VONSCHENCK, H ;
SMITH, U .
JOURNAL OF INTERNAL MEDICINE, 1993, 233 (04) :327-332
[2]  
BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
[3]   Pathogenesis of type 2 diabetes - Insulin resistance [J].
Boden, G .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2001, 30 (04) :801-+
[4]  
BROWN S, 1990, CLIN CHEM, V36, P995
[5]  
Chambless L E, 1992, Ann Epidemiol, V2, P723
[6]   SHORT-TERM INTRAINDIVIDUAL VARIABILITY IN LIPOPROTEIN MEASUREMENTS - THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY [J].
CHAMBLESS, LE ;
MCMAHON, RP ;
BROWN, SA ;
PATSCH, W ;
HEISS, G ;
SHEN, YL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (09) :1069-1081
[7]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[8]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[9]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[10]  
ECKFELDT JH, 1994, ARCH PATHOL LAB MED, V118, P496